Breaking News
22 hours ago
Vaibhavi M.

Taro Pharmaceutical launches AB-rated perampanel 0.5 mg/mL oral suspension, a generic equivalent to Fycompa, opening formulary substitution pathways.
Vaibhavi M.

60 Degrees Pharma pivots castanospermine toward prescription drug development after FDA NDI discussions, securing an exclusive option with Florida State University.
Vaibhavi M.

3PBIOVIAN outlines how early process design decisions in viral vector manufacturing determine GMP success at commercial scale.
Vaibhavi M.

Stipple Bio names Roland Gendron as CBO to lead business development and partnerships as STP-100 advances toward clinical studies on the back of a $100M Series A financing.
Simantini Singh Deo